Regal Investment Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Regal Investment Advisors LLC

  • $1.4 Billion
  • Q3 2024

A detailed history of Regal Investment Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Regal Investment Advisors LLC holds 1,978 shares of VRTX stock, worth $903,886. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,978
Previous 2,056 3.79%
Holding current value
$903,886
Previous $963,000 4.57%
% of portfolio
0.07%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$460.0 - $505.78 $35,880 - $39,450
-78 Reduced 3.79%
1,978 $919,000
Q2 2024

Aug 14, 2024
BUY
$392.81 - $485.53 $28,675 - $35,443
73 Added 3.68%
2,056 $963,000
Q1 2024

May 15, 2024
BUY
$407.69 - $446.08 $20,792 - $22,750
51 Added 2.64%
1,983 $828,000
Q4 2023

Feb 14, 2024
BUY
$343.0 - $410.68 $273,371 - $327,311
797 Added 70.22%
1,932 $786,000
Q3 2023

Nov 13, 2023
SELL
$338.18 - $362.46 $9,130 - $9,786
-27 Reduced 2.32%
1,135 $394,000
Q2 2023

Aug 11, 2023
BUY
$314.42 - $351.91 $45,590 - $51,026
145 Added 14.26%
1,162 $408,000
Q1 2023

May 11, 2023
SELL
$283.23 - $323.1 $1.12 Million - $1.28 Million
-3,970 Reduced 79.61%
1,017 $320,000
Q4 2022

Mar 01, 2023
SELL
$285.76 - $321.48 $201,175 - $226,321
-704 Reduced 12.37%
4,987 $1.44 Million
Q3 2022

Nov 15, 2022
BUY
$273.83 - $305.53 $126,509 - $141,154
462 Added 8.84%
5,691 $1.65 Million
Q2 2022

Aug 09, 2022
BUY
$234.96 - $292.55 $532,889 - $663,503
2,268 Added 76.6%
5,229 $1.47 Million
Q1 2022

May 09, 2022
BUY
$221.42 - $260.97 $239,797 - $282,630
1,083 Added 57.67%
2,961 $773,000
Q4 2021

Feb 10, 2022
BUY
$177.01 - $223.45 $3,009 - $3,798
17 Added 0.91%
1,878 $412,000
Q3 2021

Nov 05, 2021
BUY
$181.39 - $202.99 $31,199 - $34,914
172 Added 10.18%
1,861 $338,000
Q2 2021

Aug 09, 2021
BUY
$187.49 - $221.1 $316,670 - $373,437
1,689 New
1,689 $341,000
Q1 2021

May 12, 2021
SELL
$207.02 - $241.31 $217,578 - $253,616
-1,051 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$207.01 - $276.09 $217,567 - $290,170
1,051 New
1,051 $248,000
Q3 2020

Nov 13, 2020
SELL
$255.65 - $303.1 $326,976 - $387,664
-1,279 Closed
0 $0
Q2 2020

Aug 03, 2020
BUY
$225.48 - $295.8 $288,388 - $378,328
1,279 New
1,279 $371,000
Q1 2020

May 12, 2020
SELL
$199.77 - $247.81 $320,031 - $396,991
-1,602 Closed
0 $0
Q4 2019

Jan 29, 2020
BUY
$166.71 - $223.91 $267,069 - $358,703
1,602 New
1,602 $351,000

Others Institutions Holding VRTX

# of Institutions
1,726
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $117B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Regal Investment Advisors LLC Portfolio

Follow Regal Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email